Table 5. Strength of Recommendation Taxonomy Table
Strength of Recommendation
Patients born between 1945 and 1965 or with risk factors should be screened for hepatitis C.B
Patients for whom there is no contraindication should be offered treatment for hepatitis C.A
Patients with the hepatitis C genotype 1 should be treated with triple therapy (peginterferon-α, ribavirin, and a protease inhibitor).A
Patients without documented immunity to hepatitis A and B should be offered vaccination.C
Patients with chronic hepatitis C should be encouraged to abstain from alcohol and offered treatment if needed.C
Nonsteroidal anti-inflammatory drugs should be avoided in patients with cirrhosis. Acetaminophen and opioids can be used at low doses if needed.C
Statin drugs may be used in patients with hepatitis C if serum aminotransferase levels are <5 times the upper limit of normal.C
Patients with cirrhosis due to hepatitis C should be screened for hepatocellular carcinoma with annual ultrasound testing.C